Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.15 | 0.008 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.009 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |